206 related articles for article (PubMed ID: 27544051)
21. Effect of alterations of key active site residues in O6-alkylguanine-DNA Alkyltransferase on its ability to modulate the genotoxicity of 1,2-dibromoethane.
Liu L; Watanabe K; Fang Q; Williams KM; Guengerich FP; Pegg AE
Chem Res Toxicol; 2007 Jan; 20(1):155-63. PubMed ID: 17226938
[TBL] [Abstract][Full Text] [Related]
22. Alkylation damage repair protein O6-alkylguanine-DNA alkyltransferase from the hyperthermophiles Aquifex aeolicus and Archaeoglobus fulgidus.
Kanugula S; Pegg AE
Biochem J; 2003 Oct; 375(Pt 2):449-55. PubMed ID: 12892560
[TBL] [Abstract][Full Text] [Related]
23. Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase.
Ishiguro K; Zhu YL; Shyam K; Penketh PG; Baumann RP; Sartorelli AC
Biochem Pharmacol; 2010 Nov; 80(9):1317-25. PubMed ID: 20654586
[TBL] [Abstract][Full Text] [Related]
24. Cytosine methylation effects on the repair of O6-methylguanines within CG dinucleotides.
Guza R; Ma L; Fang Q; Pegg AE; Tretyakova N
J Biol Chem; 2009 Aug; 284(34):22601-10. PubMed ID: 19531487
[TBL] [Abstract][Full Text] [Related]
25. A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine.
Souliotis VL; Kyrtopoulos SA
Cancer Res; 1989 Dec; 49(24 Pt 1):6997-7001. PubMed ID: 2684406
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the role of tyrosine-114 in the activity of human O6-alkylguanine-DNA alkyltranferase.
Goodtzova K; Kanugula S; Edara S; Pegg AE
Biochemistry; 1998 Sep; 37(36):12489-95. PubMed ID: 9730821
[TBL] [Abstract][Full Text] [Related]
27. Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanine.
Griffin RJ; Arris CE; Bleasdale C; Boyle FT; Calvert AH; Curtin NJ; Dalby C; Kanugula S; Lembicz NK; Newell DR; Pegg AE; Golding BT
J Med Chem; 2000 Nov; 43(22):4071-83. PubMed ID: 11063604
[TBL] [Abstract][Full Text] [Related]
28. Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.
Crone TM; Goodtzova K; Edara S; Pegg AE
Cancer Res; 1994 Dec; 54(23):6221-7. PubMed ID: 7954470
[TBL] [Abstract][Full Text] [Related]
29. Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors.
Dolan ME; Posner M; Karrison T; Radosta J; Steinberg G; Bertucci D; Vujasin L; Ratain MJ
Clin Cancer Res; 2002 Aug; 8(8):2519-23. PubMed ID: 12171878
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
Liu L; Schwartz S; Davis BM; Gerson SL
Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of human O(6)-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O(6)-benzylguanine.
Pegg AE; Goodtzova K; Loktionova NA; Kanugula S; Pauly GT; Moschel RC
J Pharmacol Exp Ther; 2001 Mar; 296(3):958-65. PubMed ID: 11181929
[TBL] [Abstract][Full Text] [Related]
32. Point mutations at multiple sites including highly conserved amino acids maintain activity, but render O6-alkylguanine-DNA alkyltransferase insensitive to O6-benzylguanine.
Xu-Welliver M; Pegg AE
Biochem J; 2000 Apr; 347(Pt 2):519-26. PubMed ID: 10749682
[TBL] [Abstract][Full Text] [Related]
33. Human O(6)-alkylguanine-DNA alkyltransferase: protection against alkylating agents and sensitization to dibromoalkanes.
Abril N; Luque-Romero FL; Christians FC; Encell LP; Loeb LA; Pueyo C
Carcinogenesis; 1999 Nov; 20(11):2089-94. PubMed ID: 10545410
[TBL] [Abstract][Full Text] [Related]
34. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
[TBL] [Abstract][Full Text] [Related]
35. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
36. Molecular imaging of alkylguanine-DNA alkyltransferase: further evaluation of radioiodinated derivatives of O6-benzylguanine.
Shankar S; Zalutsky MR; Friedman H; Vaidyanathan G
Nucl Med Biol; 2006 Apr; 33(3):399-407. PubMed ID: 16631089
[TBL] [Abstract][Full Text] [Related]
37. The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by O6-alkylguanine-DNA alkyltransferase variants.
Mijal RS; Thomson NM; Fleischer NL; Pauly GT; Moschel RC; Kanugula S; Fang Q; Pegg AE; Peterson LA
Chem Res Toxicol; 2004 Mar; 17(3):424-34. PubMed ID: 15025514
[TBL] [Abstract][Full Text] [Related]
38. O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell lines.
Johnson SP; Kamen BA; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 2007 Nov; 60(6):883-9. PubMed ID: 17333191
[TBL] [Abstract][Full Text] [Related]
39. HPLC-ESI+-MS/MS analysis of N7-guanine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene.
Goggin M; Loeber R; Park S; Walker V; Wickliffe J; Tretyakova N
Chem Res Toxicol; 2007 May; 20(5):839-47. PubMed ID: 17455958
[TBL] [Abstract][Full Text] [Related]
40. Radioiodinated O(6)-Benzylguanine derivatives containing an azido function.
Vaidyanathan G; White B; Affleck DJ; McDougald D; Zalutsky MR
Nucl Med Biol; 2011 Jan; 38(1):77-92. PubMed ID: 21220131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
